1084 related articles for article (PubMed ID: 28596306)
1. Mendelian randomisation in cardiovascular research: an introduction for clinicians.
Bennett DA; Holmes MV
Heart; 2017 Sep; 103(18):1400-1407. PubMed ID: 28596306
[TBL] [Abstract][Full Text] [Related]
2. An Overview of Methods and Exemplars of the Use of Mendelian Randomisation in Nutritional Research.
Bennett DA; Du H
Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014914
[No Abstract] [Full Text] [Related]
3. Genetic risk factors and Mendelian randomization in cardiovascular disease.
Swerdlow DI; Hingorani AD; Humphries SE
Curr Cardiol Rep; 2015 May; 17(5):33. PubMed ID: 25894797
[TBL] [Abstract][Full Text] [Related]
4. Mendelian randomisation applied to drug development in cardiovascular disease: a review.
Mokry LE; Ahmad O; Forgetta V; Thanassoulis G; Richards JB
J Med Genet; 2015 Feb; 52(2):71-9. PubMed ID: 25515070
[TBL] [Abstract][Full Text] [Related]
5. Mendelian randomisation analysis of clustered causal effects of body mass on cardiometabolic biomarkers.
Conde S; Xu X; Guo H; Perola M; Fazia T; Bernardinelli L; Berzuini C
BMC Bioinformatics; 2018 Jul; 19(Suppl 7):195. PubMed ID: 30066639
[TBL] [Abstract][Full Text] [Related]
6. A data-driven approach for studying the role of body mass in multiple diseases: a phenome-wide registry-based case-control study in the UK Biobank.
Hyppönen E; Mulugeta A; Zhou A; Santhanakrishnan VK
Lancet Digit Health; 2019 Jul; 1(3):e116-e126. PubMed ID: 33323262
[TBL] [Abstract][Full Text] [Related]
7. Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies.
Li X; Meng X; Timofeeva M; Tzoulaki I; Tsilidis KK; Ioannidis JP; Campbell H; Theodoratou E
BMJ; 2017 Jun; 357():j2376. PubMed ID: 28592419
[No Abstract] [Full Text] [Related]
8. Mendelian randomization for cardiovascular diseases: principles and applications.
Larsson SC; Butterworth AS; Burgess S
Eur Heart J; 2023 Dec; 44(47):4913-4924. PubMed ID: 37935836
[TBL] [Abstract][Full Text] [Related]
9. Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis.
White J; Sofat R; Hemani G; Shah T; Engmann J; Dale C; Shah S; Kruger FA; Giambartolomei C; Swerdlow DI; Palmer T; McLachlan S; Langenberg C; Zabaneh D; Lovering R; Cavadino A; Jefferis B; Finan C; Wong A; Amuzu A; Ong K; Gaunt TR; Warren H; Davies TL; Drenos F; Cooper J; Ebrahim S; Lawlor DA; Talmud PJ; Humphries SE; Power C; Hypponen E; Richards M; Hardy R; Kuh D; Wareham N; Ben-Shlomo Y; Day IN; Whincup P; Morris R; Strachan MW; Price J; Kumari M; Kivimaki M; Plagnol V; Whittaker JC; ; Smith GD; Dudbridge F; Casas JP; Holmes MV; Hingorani AD;
Lancet Diabetes Endocrinol; 2016 Apr; 4(4):327-36. PubMed ID: 26781229
[TBL] [Abstract][Full Text] [Related]
10. Mendelian randomization: how genetics is pushing the boundaries of epidemiology to identify new causes of heart disease.
Thanassoulis G
Can J Cardiol; 2013 Jan; 29(1):30-6. PubMed ID: 23199790
[TBL] [Abstract][Full Text] [Related]
11. Body mass index and all-cause mortality in HUNT and UK biobank studies: revised non-linear Mendelian randomisation analyses.
Burgess S; Sun YQ; Zhou A; Buck C; Mason AM; Mai XM
BMJ Open; 2024 May; 14(5):e081399. PubMed ID: 38749693
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. [Mendelian randomisation - a genetic approach to an epidemiological method].
Stensrud MJ
Tidsskr Nor Laegeforen; 2016 Jun; 136(11):1002-5. PubMed ID: 27325033
[TBL] [Abstract][Full Text] [Related]
14. Uric acid and cardiovascular risk: What genes can say.
Kei A; Koutsouka F; Makri A; Elisaf M
Int J Clin Pract; 2018 Jan; 72(1):. PubMed ID: 29250870
[TBL] [Abstract][Full Text] [Related]
15. Genetic instrumental variable analysis: time to call mendelian randomization what it is. The example of alcohol and cardiovascular disease.
Mukamal KJ; Stampfer MJ; Rimm EB
Eur J Epidemiol; 2020 Feb; 35(2):93-97. PubMed ID: 31761964
[TBL] [Abstract][Full Text] [Related]
16. Causal inference on neuroimaging data with Mendelian randomisation.
Taschler B; Smith SM; Nichols TE
Neuroimage; 2022 Sep; 258():119385. PubMed ID: 35714886
[TBL] [Abstract][Full Text] [Related]
17. Dementia prevention: the Mendelian randomisation perspective.
Anderson EL; Davies NM; Korologou-Linden R; Kivimäki M
J Neurol Neurosurg Psychiatry; 2024 Mar; 95(4):384-390. PubMed ID: 37967935
[TBL] [Abstract][Full Text] [Related]
18. Mendelian Randomization as a Tool for Cardiovascular Research: A Review.
Levin MG; Burgess S
JAMA Cardiol; 2024 Jan; 9(1):79-89. PubMed ID: 37938820
[TBL] [Abstract][Full Text] [Related]
19. Mendelian randomisation for mediation analysis: current methods and challenges for implementation.
Carter AR; Sanderson E; Hammerton G; Richmond RC; Davey Smith G; Heron J; Taylor AE; Davies NM; Howe LD
Eur J Epidemiol; 2021 May; 36(5):465-478. PubMed ID: 33961203
[TBL] [Abstract][Full Text] [Related]
20. Using genetic association data to guide drug discovery and development: Review of methods and applications.
Burgess S; Mason AM; Grant AJ; Slob EAW; Gkatzionis A; Zuber V; Patel A; Tian H; Liu C; Haynes WG; Hovingh GK; Knudsen LB; Whittaker JC; Gill D
Am J Hum Genet; 2023 Feb; 110(2):195-214. PubMed ID: 36736292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
